Reuters logo
3 个月内
BRIEF-Onconova Therapeutics says entered market issuance sales agreement with FBR Capital
2017年4月20日 / 晚上9点58分 / 3 个月内

BRIEF-Onconova Therapeutics says entered market issuance sales agreement with FBR Capital

1 分钟阅读

April 20 (Reuters) - Onconova Therapeutics Inc:

* Onconova Therapeutics- on dec. 5, 2016, co entered into at market issuance sales agreement with FBR capital to create an at--market equity program

* Onconova Therapeutics Inc - effective april 19, 2017, company terminated sales agreement and related atm program - sec filing

* Onconova Therapeutics Inc - has decided to terminate sales agreement because it does not intend to utilize sales agreement to raise additional capital

* Onconova Therapeutics Inc - company will not incur any termination penalties as a result of its termination of sales agreement Source text - bit.ly/2p0N6Wx Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below